Skip to the main content.
HUB of
Biotherapeutic
Intelligence™
Protein Production
Overview
 
Online Store

Explore now

See our latest upcoming event
Tell me moreto Events
 
Connect with IPA

Contact usto Contact
Follow us on LinkedInto LinkedIn

HUB of
Biotherapeutic
Intelligence™
See our latest upcoming event
Tell me moreto Events
 
Connect with IPA

Contact usto Contact
Follow us on LinkedInto LinkedIn

HUB of
Biotherapeutic
Intelligence™
Applications
Insights
See our latest upcoming event
Tell me moreto Events
 
Connect with IPA

Contact usto Contact
Follow us on LinkedInto LinkedIn

HUB of
Biotherapeutic
Intelligence™
See our latest upcoming event
Tell me moreto Events
 
Connect with IPA

Contact usto Contact
Follow us on LinkedInto LinkedIn

HUB of
Biotherapeutic
Intelligence™
See our latest upcoming event
Tell me moreto Events
 
Connect with IPA

Contact usto Contact
Follow us on LinkedInto LinkedIn

IPA Leadership

ENGINEERED for the Biotherapeutic Race

Hub of biotherapeutic intelligence
Ingrid Brands MD PhD

Ingrid Brands MD PhD

General Manager, Biostrand Europe (a subsidiary of IPA)

Ingrid Brands, a co-founder and former CEO of BioStrand in 2019, now holds the position of General Manager, guiding the company's path towards becoming a global leader in the multi-omics research domain. With over two decades of experience in research, management roles, and clinical practice, she is apt at merging knowledge from disparate domains into innovative solutions and business synergies. Her dedication to innovation and precision medicine serves as the driving force behind BioStrand's achievements. Dr. Brands holds a Ph.D. in Neurorehabilitation from the University of Maastricht and graduated magna cum laude from the University of Leuven with a specialization in Physical Medicine and Rehabilitation. 

IPA News

Go

Connect with IPA